198 related articles for article (PubMed ID: 35805116)
1. Cytoplasmic LMO2-LDB1 Complex Activates STAT3 Signaling through Interaction with gp130-JAK in Glioma Stem Cells.
Park CG; Choi SH; Lee SY; Eun K; Park MG; Jang J; Jeong HJ; Kim SJ; Jeong S; Lee K; Kim H
Cells; 2022 Jun; 11(13):. PubMed ID: 35805116
[TBL] [Abstract][Full Text] [Related]
2. LMO2 Oncoprotein Stability in T-Cell Leukemia Requires Direct LDB1 Binding.
Layer JH; Alford CE; McDonald WH; Davé UP
Mol Cell Biol; 2016 Feb; 36(3):488-506. PubMed ID: 26598604
[TBL] [Abstract][Full Text] [Related]
3. LMO2 promotes the development of AML through interaction with transcription co-regulator LDB1.
Lu L; Wang J; Fang F; Guo A; Jiang S; Tao Y; Zhang Y; Li Y; Zhang K; Zhang Z; Zhuo R; Chu X; Li X; Tian Y; Ma L; Sang X; Chen Y; Yu J; Yang Y; Cao H; Gao J; Lu J; Hu S; Pan J; He H
Cell Death Dis; 2023 Aug; 14(8):518. PubMed ID: 37573405
[TBL] [Abstract][Full Text] [Related]
4. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.
Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H
Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Lhx2 suppresses proliferation of human T cell acute lymphoblastic leukemia-derived cells, partly by reducing LMO2 protein levels.
Miyashita K; Kitajima K; Goyama S; Kitamura T; Hara T
Biochem Biophys Res Commun; 2018 Jan; 495(3):2310-2316. PubMed ID: 29278703
[TBL] [Abstract][Full Text] [Related]
6. The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation.
Visvader JE; Mao X; Fujiwara Y; Hahm K; Orkin SH
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13707-12. PubMed ID: 9391090
[TBL] [Abstract][Full Text] [Related]
7. LDB1 Enforces Stability on Direct and Indirect Oncoprotein Partners in Leukemia.
Layer JH; Christy M; Placek L; Unutmaz D; Guo Y; Davé UP
Mol Cell Biol; 2020 May; 40(12):. PubMed ID: 32229578
[TBL] [Abstract][Full Text] [Related]
8. Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Vyas P; Patient R; Porcher C; Mancini EJ
Blood; 2011 Feb; 117(7):2146-56. PubMed ID: 21076045
[TBL] [Abstract][Full Text] [Related]
9. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
[TBL] [Abstract][Full Text] [Related]
10. Solution structure of a tethered Lmo2(LIM2) /Ldb1(LID) complex.
Dastmalchi S; Wilkinson-White L; Kwan AH; Gamsjaeger R; Mackay JP; Matthews JM
Protein Sci; 2012 Nov; 21(11):1768-74. PubMed ID: 22936624
[TBL] [Abstract][Full Text] [Related]
11. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the interleukin-6 receptor subunit glycoprotein 130 complex and its signaling by LMO4 interaction.
Novotny-Diermayr V; Lin B; Gu L; Cao X
J Biol Chem; 2005 Apr; 280(13):12747-57. PubMed ID: 15677447
[TBL] [Abstract][Full Text] [Related]
13. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.
Kim H; Baumann H
Mol Cell Biol; 1999 Aug; 19(8):5326-38. PubMed ID: 10409724
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for the recognition of ldb1 by the N-terminal LIM domains of LMO2 and LMO4.
Deane JE; Mackay JP; Kwan AH; Sum EY; Visvader JE; Matthews JM
EMBO J; 2003 May; 22(9):2224-33. PubMed ID: 12727888
[TBL] [Abstract][Full Text] [Related]
15. Ldb1 is required for Lmo2 oncogene-induced thymocyte self-renewal and T-cell acute lymphoblastic leukemia.
Li L; Mitra A; Cui K; Zhao B; Choi S; Lee JY; Stamos DB; El-Khoury D; Warzecha C; Pfeifer K; Hardwick J; Zhao K; Venters B; Davé UP; Love PE
Blood; 2020 Jun; 135(25):2252-2265. PubMed ID: 32181817
[TBL] [Abstract][Full Text] [Related]
16. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
[TBL] [Abstract][Full Text] [Related]
17. Elucidation of the role of LMO2 in human erythroid cells.
Inoue A; Fujiwara T; Okitsu Y; Katsuoka Y; Fukuhara N; Onishi Y; Ishizawa K; Harigae H
Exp Hematol; 2013 Dec; 41(12):1062-76.e1. PubMed ID: 24041784
[TBL] [Abstract][Full Text] [Related]
18. Purification, crystallization and preliminary X-ray analysis of a fusion of the LIM domains of LMO2 and the LID domain of Ldb1.
El Omari K; Porcher C; Mancini EJ
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Nov; 66(Pt 11):1466-9. PubMed ID: 21045296
[TBL] [Abstract][Full Text] [Related]
19. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
Halfter H; Postert C; Friedrich M; Ringelstein EB; Stögbauer F
Brain Res Mol Brain Res; 2000 Sep; 80(2):198-206. PubMed ID: 11038252
[TBL] [Abstract][Full Text] [Related]
20. The VHL tumor suppressor protein regulates tumorigenicity of U87-derived glioma stem-like cells by inhibiting the JAK/STAT signaling pathway.
Kanno H; Sato H; Yokoyama TA; Yoshizumi T; Yamada S
Int J Oncol; 2013 Mar; 42(3):881-6. PubMed ID: 23338840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]